A61K 31/305
Mercury compounds
A61K31/305 (Mercury compounds) appears on 44 US grants and 57 published applications in this corpus.
Search patents in A61K- Granted patents
- 44
- Published applications
- 57
- Assignees
- 50
- Inventors
- 173
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 4 |
| 2004 | 2 | 3 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 3 |
| 2012 | 2 | 2 |
| 2013 | 0 | 5 |
| 2014 | 4 | 2 |
| 2015 | 1 | 6 |
| 2016 | 1 | 2 |
| 2017 | 3 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 3 |
| 2020 | 0 | 1 |
| 2021 | 2 | 4 |
| 2022 | 3 | 3 |
| 2023 | 1 | 3 |
| 2024 | 3 | 4 |
| 2025 | 1 | 0 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Eye drop composition11 Nov 2025US 12,465,658 B2Aratana Therapeutics, Inc.
- Use of salidroside derivative in external preparation for skin whitening24 Dec 2024US 12,171,856 B2Shanghai Cheermore Biological Technology Co., Ltd.
- Inhibitors of SARM1 NADase activity and uses thereof20 Feb 2024US 11,903,935 B2Disarm Therapeutics, Inc.
- Eye drop composition20 Feb 2024US 11,904,024 B2Aratana Therapeutics, Inc.
- Use of gTso thal in manufacturing medicament for promotion of MS-275 to cross blood-brain barrier18 Jul 2023US 11,701,338 B2Northwest Institute of Plateau Biology, Chinese Academy of Sciences
- Methods of modulating atxn2 expression21 May 2026US 2026/0137707 A1University of Utah Research Foundation
- Complexes and Compounds of Mercaptophenols and Curcumin for Therapeutic Applications23 Apr 2026US 2026/0109720 A1
- Eye drop composition12 Mar 2026US 2026/0069720 A1Aratana Therapeutics, Inc.
- Treatment of circadian rhythm disorders24 Oct 2024US 2024/0350451 A1Vanda Pharmaceuticals Inc.
- Inhibitors of sarm1 nadase activity and uses thereof18 Jul 2024US 2024/0238264 A1Disarm Therapeutics, Inc.
Most cited
By later US patents
- Alkaline and acid phosphatase inhibitors in treatment of neurological disorders115US 5,567,724 ACortex Pharmaceuticals, Inc. · 1996
- Pharmaceutical combinations for treating obesity and food craving102US 6,207,699 B12001
- Enzyme-orthokeratology57US 5,270,051 A1993
- Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor36US 5,260,059 AThe State of Oregon Acting by and through the State Board of Higher Education on Behalf of Oregon Health Sciences University · 1993
- Enzyme-orthokeratology32US 5,626,865 AAdvanced Corneal Systems, Inc. · 1997